
    
      A RCT was carried out to check the efficacy of Montelukast as an adjunct to scaling and root
      planing. The patients were randomised to either test group (SRP + Montelukast) and control
      group (SRP). Clinical parameters were assessed at baseline, 3 weeks and 6 weeks. Serum
      C-reactive protein levels were assessed at baseline, 3 weeks and 6 weeks.
    
  